Prognostic Significance of Raised Cardiac Troponin T in Patients Presenting with Acute Limb Ischaemia  by Rittoo, D. et al.
Eur J Vasc Endovasc Surg 32, 500e503 (2006)
doi:10.1016/j.ejvs.2006.04.005, available online at http://www.sciencedirect.com onPrognostic Significance of Raised Cardiac Troponin T in Patients
Presenting with Acute Limb Ischaemia
D. Rittoo,1* M. Stahnke,2 C. Lindesay,3 E. Grocott,3 N. Hickey3 and R. Downing3
Departments of 1Vascular Surgery, 2Radiology, Selly Oak Hospital,
University Hospital Birmingham NHS Foundation Trust, and 3Department of Vascular Surgery,
Worcestershire Royal Hospital, Worcestershire Acute Hospitals NHS Trust, UK
Objective. To study the relation between serum cardiac troponin T (cTnT) and mortality in patients presenting with acute
limb ischaemia secondary to an embolism.
Material and methods. A two years prospective study of all patients admitted to the vascular unit with a diagnosis of
acute limb ischaemia secondary to an embolism. On admission all patients had an ECG. A blood sample was taken for
measurement of cTnT, CRP, serum biochemistry, full blood count and clotting. All embolectomies were performed under
local anaesthesia. Patients were followed until discharge from hospital and up to twelve months after surgery.
Results. There were 37 patients with lower limb and 2 patients with upper limb ischaemia. Twenty four patients were
female and fifteen were male, with the mean age of 76 years (50e95) for women and 84 years (77e90) for men. Seventeen
patients (44%) had a raised cTnT. The patients with raised cTnTwere older than those with normal cTnT [86y (77e92) vs
77y (51e95), p¼ 0.01, t test]. The mean cTnT was 0.20 mg/L (range: 0.11e0.27). Only two patients with raised cTnT
gave a history of chest pains. All of the patients with an elevated cTnT had also raised CRP. There was no significant dif-
ference in the serum creatinine in the group of patients with elevated cTnTcompared to those with normal cTnT [112 mmol/
L (range 98e159) vs 119 mmol/L (range: 47e177), p¼ ns]. The cumulative survival for cTnTþ patients at 7 days was
53% and that of cTnT patients was 100%. The cumulative survival for cTnTþ and cTnT patients was statistically
different (p¼ 0.0000, c2¼ 13.1, Log Rank test). Using regression analysis, an elevated cTnTwas found to be an indepen-
dent predictor of outcome.
Conclusion. A significant proportion of patients presenting with an acutely ischaemic limb have an elevated cTnT. An
elevated cTnT may be an early marker of overall disease severity and a predictor of outcome.
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Several studies have demonstrated that minor eleva-
tions in perioperative serum troponin (cTnT) concen-
trations are associated with significantly lower long
term survival after vascular surgery.1,2 In these pa-
tients underlying heart disease is often unrecognised
due to decreased exercise tolerance from peripheral
vascular disease. The most common aetiological
factor for an acutely ischaemic leg is an embolus of
cardiac origin. Less common factors include in situ
thrombosis or a thrombosed popliteal aneurysm.
Patients presenting with an acutely ischaemic leg
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may not be apparent on admission to hospital. Mor-
tality following successful embolectomy is not insig-
nificant. Early identification of patients at risk may
lower both, morbidity and mortality, and improve
the postoperative outcome. We studied prospectively,
the relation between cTnT and mortality in patients
presenting with acute limb ischaemia secondary to
an embolism.
Material and Method
We studied patients who were referred to a vascular
unit with acute limb ischaemia over the period of 24
months (October 2002 to October 2004). On admis-
sion every patients were assessed a specialist regis-
trar and a consultant vascular surgeon. All patientsrved.
501Raised cTnT in Patients with Acute Limb Ischaemiaunderwent a full cardiovascular examination, followed
by a 12 lead ECG and a Colour Flow Duplex scan of
the ischaemic limb and the abdominal aorta. The ankle
brachial pressure index (ABPI) was also measured
whenever possible. But this was not possible in the
majority of patients and had to be abandoned. Blood
samples were taken for a full blood count, urea and
electrolytes, Troponin T (cTnT) and C reactive protein
(CRP). The blood test and the ECG were repeated
twelve hours after admission. For patent reasons
cTnTassay has a single manufacturer (Roche Diagnos-
tics). The current version uses a third generation tropo-
nin T (Elecsys Troponin T; Modular Analytics E170).
The assay uses two monoclonal antibodies specifically
directed against human cardiac troponin T. It has
a lower limit of detection of 0.01 ug/L and an upper
limit of the reference interval (99th percentile of
a healthy population) of <0.01 mg/L. The serum
concentration of cTnTat which the coefficient of varia-
tion is 10% is 0.03 mg/L. According to themanufacturer
(information obtained from the package insert), the
monoclonal antibodies used in the assay have negligi-
ble (0.001%) cross-reactivity with human skeletal
muscle troponin T.
All embolectomies were performed under local
anaesthesia using 1% plain lignocaine (max dose:
5 mg/kg). A completion angiogram was performed
to establish complete clearance of the vessel. The ar-
teriotomy was repaired with a vein patch using
6-0 polypropylene. All patients were subsequently
commenced on an intravenous heparin infusion to
maintain an APTT ratio of 2.0, pending anticoagu-
lation with warfarin with a target INR of 2.0. All
patients had a cardiac echocardiography to look
for the potential source of emboli. Patients with
ECG changes and raised cTnT levels were referred
to a cardiologist perioperatively. All patients were
followed until discharge from hospital and followed
in the outpatients for 12 months.
Statistic
Categorial data were analysed using the Chi-square
test. The Pearson test was used to determine the cor-
relation between cTnT and CRP. Survival was deter-
mined using Kaplan Meier’s lifetime table method.
Regression analysis was used to determine the most
significant factor affecting survival. To avoid collin-
earity, the predictors entered into the model were
age, sex, cTnT, CRP, ischaemic heart disease (IHD)
and aspirin therapy.Results
Of the 119 patients admitted to the vascular unit with
limb related complaints 39 had an acutely ischaemic
limb. The demographic data is displayed in Table 1.
There were 37 patients with lower limb and 2 patients
with upper limb ischaemia. Twenty four patients were
female and fifteen were male, with the mean age of 76
years (50e95) for women and 84 years (77e90) for
men. Eighteen patients had a history of ischaemic
heart disease and two gave a history of chest pain
or recent myocardial infarct. Eleven patients had a
history of hypertension, seven of diabetes and twenty
four of atrial fibrillation. Seventeen patients (44%) had
a raised cTnT. The patients with raised cTnT were
older than those with normal cTnT [86y (77e92) vs
77y (51e95), p¼ 0.01, t test]. The mean cTnT was
0.20 mg/L (range: 0.11e0.27). Only four patients had
electrocardiographic evidence of myocardial injury
on admission. The mean cTnT in this group of
patients was 0.17 mg/L (range: 0.11e0.24). Two of
the patients with ECG changes felt generally unwell
and had chest pains. The other patients with raised
cTnT all denied chest pain and their ECGs showed
no evidence of ischaemia. This finding may suggest
silent myocardial cell damage. None of the echocar-
diograms showed any evidence of mural thrombus,
vegetation or septal defects.
All of the patients with an elevated cTnT had also
raised CRP. There was a strong correlation between
a raised cTnT and the CRP (Pearson correlation¼ 0.5,
p¼ 0.001, Fig. 1). There was no significant difference
in the serum creatinine in the group of patients with
elevated cTnT compared to those with normal cTnT
[112 mmol/L (range 98e159) vs 119 mmol/L (range:
47e177), p¼ ns].
No patients underwent an amputation. All patients
who died within 28 days of hospitalisation had raised
cTnT levels. Patients were stratified as to whether or
not their cTnT was elevated. The Kaplan Meier sur-
vival curves for the group of patients with raised tro-
ponin (cTnTþ), and those with normal troponin
(cTnT) is shown in Fig. 2. The cumulative survival
Table 1. Demographic data of patients studied
cTnT þve cTnT ve p value
Male 11 4 0.003
Female 6 18
Age (range)/year 86 (77e92) 77 (51e95) 0.01
Hypertension 3 8 ns
Ischaemic heart disease 11 7 0.04
Aspirin therapy 4 10 ns
Diabetes 3 4 ns
Atrial fibrillation 8 16 nsEur J Vasc Endovasc Surg Vol 32, November 2006
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survival for cTnTþ and cTnT patients was statisti-
cally different ( p¼ 0.0000, c2¼ 13.1, Log Rank test).
During the follow up period no further mortality
was noted at one year in all the patients studied.
Using logistic regression analysis, age (z¼1.00,
p¼ 0.3), sex (z¼ 1.64, p¼ 0.1), CRP (z¼0.68, p¼
0.5), IHD (z¼1.74, p¼ 0.08), and aspirin therapy
(z¼ 1.88, p¼ 0.06) were all not associated with out-
come. However, an elevated cTnT (z¼ 2.64, p¼
0.008) was found to be of predictor of mortality.
Discussion
One of the important findings of this study is the
observation that up to 44% of patients presenting as
an emergency with an acutely ischaemic limb show
evidence of raised cTnT. We also found that an ele-
vated cTnT on admission in these patients is associ-
ated with an increase in 28-day mortality. Elevated
cTnT however does not seem to affect mortality in
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Fig. 1. Scatterplot of CRP vs cTnT.
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Fig. 2. Kaplan Meier survival curves for cTnTþ (d) and
cTnT (- - - -) patients.Eur J Vasc Endovasc Surg Vol 32, November 2006the medium term. Troponin T and I are the most sen-
sitive markers of myocardial cell damage and may be
elevated in conditions other than acute coronary syn-
drome. Cardiac troponins are also elevated, and have
been shown to be of prognostic significance in many
conditions associated with secondary ischaemic in-
jury3 such as coronary angioplasty and arrhythmias,
pulmonary embolism,4 heart failure5 and in
conditions causing non-ischaemic myocardial injury
such as pericarditis,6 septicaemia,7 renal failure8 and
stroke.9 Elevated troponin levels correlate with a de-
crease in left ventricular function in both cardiac
and non-cardiac patients.10 Ammann et al. showed in-
dependent predictive value of raised troponin in crit-
ically ill patients. In the current study, the correlation
between cTnT on admission and mortality was strong.
A raised troponin was also found to be an indepen-
dent risk factor for mortality suggesting that the mor-
tality may be cardiac related. However as we did not
perform myocardial perfusion scan or coronary angio-
gram in these patients, the correlation between raised
cTnT on admission and reversible cardiac dysfunction
remains deductive.
The absence of chest pain and ischaemic changes
on ECG in most patients may reflect silent myocardial
cell damage. It is difficult to know from this study
whether the elevated cTnT is a primary event of car-
diac origin or a secondary event on the myocardium
by an inflammatory response triggered as a result
the acute ischaemic event in the limb. Given that
arrhythmias can cause an elevation of troponin and
that myocardial cell necrosis can cause arrhythmias
which in turn can cause embolism, it is difficult to
know whether all patients presenting with acute
limb ischaemia and raised troponin should undergo
risk stratification investigations. These issues are per-
tinent when one considers the mortality in this group
of patients. However, we acknowledge that this is
a small study and interpretation of results is therefore
limited. Whether risk stratification using cTnT, and
early risk reduction strategies will translate into
improved clinical outcome remains to be seen.
In conclusion, we found that a significant propor-
tion of patients presenting with an acutely ischaemic
limb have an elevated cTnT. We also found that an
elevated cTnT might be an early marker of overall
disease severity and a predictor of outcome.
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